Abbott Laboratories (BVL:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions PEN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	743,002	739,928	709,605	729,164	963,455	678,231
Market Cap Growth	1.96%	4.27%	-2.68%	-24.32%	42.05%	33.28%
Enterprise Value	761,676	768,178	742,525	755,379	999,065	728,994
Last Close Price	442.64	402.94	-	-	-	-
PE Ratio	15.39	14.69	33.52	27.72	34.28	41.94
PS Ratio	4.89	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.18	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.02	10.96	31.28	55.76	-	-
P/FCF Ratio	30.98	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	23.50	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.17	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	18.70	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	26.28	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	31.76	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.25	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.07	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	1.88	2.41	3.16	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.84	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.09	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.70	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.62%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.79%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	9.03%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	12.40%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.50%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	3.23%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	6.50%	2.10%	-	-	-	-
Payout Ratio	30.99%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.04%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	6.54%	2.15%	0.85%	1.40%	-0.17%	-0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.